{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:29:46Z","timestamp":1794292186198,"version":"4.9.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Talents Training Program of the Seventh People\u2019s Hospital, Shanghai University of Traditional Chinese Medicine","award":["YC2024-01"],"award-info":[{"award-number":["YC2024-01"]}]},{"name":"The 2024 Nantong University Clinical Medicine Special Research Fund Project","award":["2024LY057"],"award-info":[{"award-number":["2024LY057"]}]},{"name":"The 2024 Research Project of the Nantong Municipal Health Commission","award":["QNZ2024069"],"award-info":[{"award-number":["QNZ2024069"]}]},{"name":"The Training Program for Academic Leaders in the Health System of Pudong New Area, Shanghai","award":["PWRd2023-14"],"award-info":[{"award-number":["PWRd2023-14"]}]},{"name":"the Talents Training\u00a0Program of the Seventh People\u2019s Hospital, Shanghai University of Traditional Chinese Medicine Bei Dou Xing","award":["BDX2022-01"],"award-info":[{"award-number":["BDX2022-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00835-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T03:44:17Z","timestamp":1770003857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pulmonary origin and risk assessment of cancer-associated thrombosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Huan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiwei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"6","key":"835_CR1","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","volume":"21","author":"A Falanga","year":"2023","unstructured":"Falanga A, Marchetti M. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost. 2023;21(6):1397\u2013408. https:\/\/doi.org\/10.1016\/j.jtha.2023.02.029.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"835_CR2","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.japh.2021.06.005","volume":"61","author":"R Caputo","year":"2021","unstructured":"Caputo R, Pyle J, Kuriakose P, Lekura J. A systematic review of Apixaban in prevention and treatment of cancer-associated venous thromboembolism. J Am Pharm Assoc (2003). 2021;61(5):e26\u201338. https:\/\/doi.org\/10.1016\/j.japh.2021.06.005.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"6","key":"835_CR3","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.cell.2025.01.025","volume":"188","author":"S Lucotti","year":"2025","unstructured":"Lucotti S, Ogitani Y, Kenific CM, et al. Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2. Cell. 2025;188(6):1642\u2013e166124. https:\/\/doi.org\/10.1016\/j.cell.2025.01.025.","journal-title":"Cell"},{"issue":"11","key":"835_CR4","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.3390\/ijms25115661","volume":"25","author":"T Prouse","year":"2024","unstructured":"Prouse T, Mohammad MA, Ghosh S, et al. Pancreatic cancer and venous thromboembolism. Int J Mol Sci. 2024;25(11):5661. https:\/\/doi.org\/10.3390\/ijms25115661. Published 23 May 2024.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"835_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/jamaoncol.2023.3625","volume":"9","author":"M Aldea","year":"2023","unstructured":"Aldea M, Marinello A, Guyon D, et al. Prevalence of thromboembolic events in patients with non-small cell lung cancer and RET fusions. JAMA Oncol. 2023;9(11):1583\u20134. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3625.","journal-title":"JAMA Oncol"},{"issue":"1","key":"835_CR6","doi-asserted-by":"publisher","first-page":"e001719","DOI":"10.1136\/jitc-2020-001719","volume":"9","author":"TA Sussman","year":"2021","unstructured":"Sussman TA, Li H, Hobbs B, Funchain P, McCrae KR, Khorana AA. Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival. J Immunother Cancer. 2021;9(1):e001719. https:\/\/doi.org\/10.1136\/jitc-2020-001719.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"835_CR7","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/cncr.25004","volume":"116","author":"R Sandhu","year":"2010","unstructured":"Sandhu R, Pan CX, Wun T, et al. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer. 2010;116(11):2596\u2013603. https:\/\/doi.org\/10.1002\/cncr.25004.","journal-title":"Cancer"},{"key":"835_CR8","doi-asserted-by":"publisher","unstructured":"Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers (Basel). 2018;10(10):380. https:\/\/doi.org\/10.3390\/cancers10100380. Published 11 Oct 2018.","DOI":"10.3390\/cancers10100380"},{"issue":"10","key":"835_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.6004\/jnccn.2021.0047","volume":"19","author":"MB Streiff","year":"2021","unstructured":"Streiff MB, Holmstrom B, Angelini D, et al. Cancer-Associated venous thromboembolic Disease, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(10):1181\u2013201. https:\/\/doi.org\/10.6004\/jnccn.2021.0047. Published 15 Oct 2020.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"835_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12185-024-03716-0","volume":"119","author":"T Ikezoe","year":"2024","unstructured":"Ikezoe T. Cancer-associated thrombosis and bleeding. Int J Hematol. 2024;119(5):493\u20134. https:\/\/doi.org\/10.1007\/s12185-024-03716-0.","journal-title":"Int J Hematol"},{"issue":"21","key":"835_CR11","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.3390\/cancers15215293","volume":"15","author":"L Muscat-Baron","year":"2023","unstructured":"Muscat-Baron L, Borg AL, Attard LM, Gatt A, Riva N. Cancer-associated abdominal vein thrombosis. Cancers (Basel). 2023;15(21):5293. https:\/\/doi.org\/10.3390\/cancers15215293. Published 4 Nov 2023.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"835_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13045-022-01289-1","volume":"15","author":"C Frere","year":"2022","unstructured":"Frere C, Farge D, Schrag D, Prata P, Connors JM. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials. J Hematol Oncol. 2022;15(1):69. https:\/\/doi.org\/10.1186\/s13045-022-01289-1. Published 2022 May 21.","journal-title":"J Hematol Oncol"},{"key":"835_CR13","doi-asserted-by":"publisher","unstructured":"Jin S, Qin D, Wang C et al. Development, validation, and clinical utility of risk prediction models for cancer-associated venous thromboembolism: A retrospective and prospective cohort study. Asia Pac J Oncol Nurs. 2025;12:100691. Published 2025 Mar 22. https:\/\/doi.org\/10.1016\/j.apjon.2025.100691","DOI":"10.1016\/j.apjon.2025.100691"},{"issue":"16","key":"835_CR14","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1200\/JCO.22.00255","volume":"41","author":"A Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz A, Ay C, Grilz E, et al. A Clinical-Genetic risk score for predicting Cancer-Associated venous thromboembolism: A development and validation study involving two independent prospective cohorts. J Clin Oncol. 2023;41(16):2911\u201325. https:\/\/doi.org\/10.1200\/JCO.22.00255.","journal-title":"J Clin Oncol"},{"issue":"7","key":"835_CR15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1538-7836.2012.04754.x","volume":"10","author":"J Thaler","year":"2012","unstructured":"Thaler J, Ay C, Mackman N, et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost. 2012;10(7):1363\u201370. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04754.x.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"835_CR16","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1161\/CIRCRESAHA.122.321861","volume":"132","author":"T Dudiki","year":"2023","unstructured":"Dudiki T, Veleeparambil M, Zhevlakova I, et al. Mechanism of Tumor-Platelet communications in cancer. Circ Res. 2023;132(11):1447\u201361. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321861.","journal-title":"Circ Res"},{"key":"835_CR17","doi-asserted-by":"publisher","first-page":"116930","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177:116930. https:\/\/doi.org\/10.1016\/j.biopha.2024.116930.","journal-title":"Biomed Pharmacother"},{"key":"835_CR18","doi-asserted-by":"publisher","first-page":"103614","DOI":"10.1016\/j.redox.2025.103614","volume":"82","author":"Z Li","year":"2025","unstructured":"Li Z, Bu Y, Wang C, et al. Extracellular vesicle-packaged GBP2 from macrophages aggravates sepsis-induced acute lung injury by promoting ferroptosis in pulmonary vascular endothelial cells. Redox Biol. 2025;82:103614. https:\/\/doi.org\/10.1016\/j.redox.2025.103614.","journal-title":"Redox Biol"},{"issue":"6","key":"835_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s12276-020-0450-9","volume":"52","author":"J Holtzman","year":"2020","unstructured":"Holtzman J, Lee H. Emerging role of extracellular vesicles in the respiratory system. Exp Mol Med. 2020;52(6):887\u201395. https:\/\/doi.org\/10.1038\/s12276-020-0450-9.","journal-title":"Exp Mol Med"},{"key":"835_CR20","doi-asserted-by":"publisher","first-page":"117955492312202","DOI":"10.1177\/11795549231220297","volume":"17","author":"D Pavlovic","year":"2023","unstructured":"Pavlovic D, Niciforovic D, Markovic M, Papic D, Cancer-associated thrombosis. epidemiology, pathophysiological mechanisms, treatment, and risk assessment. Clin Med Insights Oncol. 2023;17:11795549231220297. https:\/\/doi.org\/10.1177\/11795549231220297. Published 26 Dec 2023.","journal-title":"Clin Med Insights Oncol"},{"key":"835_CR21","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.2147\/CMAR.S328918","volume":"13","author":"W Di","year":"2021","unstructured":"Di W, Xu H, Xue T, Ling C. Advances in the prediction and risk assessment of lung Cancer-associated venous thromboembolism. Cancer Manag Res. 2021;13:8317\u201327. https:\/\/doi.org\/10.2147\/CMAR.S328918. Published 4 Nov 2021.","journal-title":"Cancer Manag Res"},{"issue":"5","key":"835_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/jir.2008.0076","volume":"29","author":"S Saperstein","year":"2009","unstructured":"Saperstein S, Chen L, Oakes D, Pryhuber G, Finkelstein J. IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells. J Interferon Cytokine Res. 2009;29(5):273\u201384. https:\/\/doi.org\/10.1089\/jir.2008.0076.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"835_CR23","doi-asserted-by":"publisher","first-page":"e1010280","DOI":"10.1371\/journal.ppat.1010280","volume":"18","author":"LT Hsieh","year":"2022","unstructured":"Hsieh LT, Dos Santos SJ, Hall BS, et al. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1\u03b2, are linked to fibrin formation in buruli ulcer lesions. PLoS Pathog. 2022;18(1):e1010280. https:\/\/doi.org\/10.1371\/journal.ppat.1010280. Published 31 Jan 2021.","journal-title":"PLoS Pathog"},{"issue":"12","key":"835_CR24","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.3390\/ijms22126341","volume":"22","author":"JL Wautier","year":"2021","unstructured":"Wautier JL, Wautier MP. Endothelial cell participation in inflammatory reaction. Int J Mol Sci. 2021;22(12):6341. https:\/\/doi.org\/10.3390\/ijms22126341. Published 2021 Jun 13.","journal-title":"Int J Mol Sci"},{"key":"835_CR25","doi-asserted-by":"publisher","first-page":"864735","DOI":"10.3389\/fcvm.2022.864735","volume":"9","author":"M Pilard","year":"2022","unstructured":"Pilard M, Ollivier EL, Gourdou-Latyszenok V, Couturaud F, Lemari\u00e9 CA. Endothelial cell Phenotype, a major determinant of venous Thrombo-Inflammation. Front Cardiovasc Med. 2022;9:864735. https:\/\/doi.org\/10.3389\/fcvm.2022.864735. Published 2022 Apr 21.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"835_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","volume":"34","author":"VW van Hinsbergh","year":"2012","unstructured":"van Hinsbergh VW. Endothelium\u2013role in regulation of coagulation and inflammation. Semin Immunopathol. 2012;34(1):93\u2013106. https:\/\/doi.org\/10.1007\/s00281-011-0285-5.","journal-title":"Semin Immunopathol"},{"issue":"9","key":"835_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","volume":"14","author":"J Fang","year":"2023","unstructured":"Fang J, Lu Y, Zheng J, et al. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications. Cell Death Dis. 2023;14(9):586. https:\/\/doi.org\/10.1038\/s41419-023-06119-x. Published 4 Sep 2023.","journal-title":"Cell Death Dis"},{"issue":"4","key":"835_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1055\/s-0039-1687894","volume":"45","author":"Y Hisada","year":"2019","unstructured":"Hisada Y, Mackman N. Tissue factor and cancer: Regulation, tumor Growth, and metastasis. Semin Thromb Hemost. 2019;45(4):385\u201395. https:\/\/doi.org\/10.1055\/s-0039-1687894.","journal-title":"Semin Thromb Hemost"},{"key":"835_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41420-020-0255-6","volume":"6","author":"C Brostjan","year":"2020","unstructured":"Brostjan C, Oehler R. The role of neutrophil death in chronic inflammation and cancer. Cell Death Discov. 2020;6:26. https:\/\/doi.org\/10.1038\/s41420-020-0255-6. Published 22 Apr 2020.","journal-title":"Cell Death Discov"},{"key":"835_CR30","doi-asserted-by":"publisher","first-page":"786387","DOI":"10.3389\/fcvm.2021.786387","volume":"8","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Tao W, Shen F, Du W, Xu Z, Liu Z. The emerging role of neutrophil extracellular traps in Arterial, venous and Cancer-Associated thrombosis. Front Cardiovasc Med. 2021;8:786387. https:\/\/doi.org\/10.3389\/fcvm.2021.786387. Published 2 Dec 2021.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"835_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.lungcan.2014.02.009","volume":"84","author":"M Alexander","year":"2014","unstructured":"Alexander M, Kirsa S, Wolfe R, et al. Thromboembolism in lung cancer - an area of urgent unmet need. Lung Cancer. 2014;84(3):275\u201380.","journal-title":"Lung Cancer"},{"issue":"2","key":"835_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1759-7714.14260","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Shi Z, Yi J, et al. Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism. Thorac Cancer. 2022;13(2):247\u201356. https:\/\/doi.org\/10.1111\/1759-7714.14260.","journal-title":"Thorac Cancer"},{"issue":"3","key":"835_CR33","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.rpth.2023.100123","volume":"7","author":"Y Hisada","year":"2023","unstructured":"Hisada Y, Mackman N. Mechanisms of cancer-associated thrombosis. Res Pract Thromb Haemost. 2023;7(3):100123. https:\/\/doi.org\/10.1016\/j.rpth.2023.100123. Published 15 Mar 2023.","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"835_CR34","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.21037\/tcr-20-3287","volume":"10","author":"M Barlow","year":"2021","unstructured":"Barlow M, Hamilton W, Ukoumunne OC, Bailey SER. The association between thrombocytosis and subtype of lung cancer: a systematic review and meta-analysis. Transl Cancer Res. 2021;10(3):1249\u201360. https:\/\/doi.org\/10.21037\/tcr-20-3287.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"835_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40248-015-0021-4","volume":"10","author":"C Vitale","year":"2015","unstructured":"Vitale C, D\u2019Amato M, Calabr\u00f2 P, Stanziola AA, Mormile M, Molino A. Venous thromboembolism and lung cancer: a review. Multidiscip Respir Med. 2015;10(1):28. https:\/\/doi.org\/10.1186\/s40248-015-0021-4. Published 15 Sep 2015.","journal-title":"Multidiscip Respir Med"},{"issue":"17","key":"835_CR36","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.3390\/cancers14174127","volume":"14","author":"P Ruiz-Artacho","year":"2022","unstructured":"Ruiz-Artacho P, Lecumberri R, Trujillo-Santos J, et al. Cancer histology and natural history of patients with lung cancer and venous thromboembolism. Cancers (Basel). 2022;14(17):4127. https:\/\/doi.org\/10.3390\/cancers14174127. Published 26 Aug 2022.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"835_CR37","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1097\/JS9.0000000000002534","volume":"111","author":"W Zhang","year":"2025","unstructured":"Zhang W, Yue S, Fang H, et al. New perspectives on the potential mechanisms, prevention and treatment of deep vein thrombosis complicated by lung cancer. Int J Surg. 2025;111(7):4647\u201365. https:\/\/doi.org\/10.1097\/JS9.0000000000002534.","journal-title":"Int J Surg"},{"issue":"11","key":"835_CR38","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1161\/ATVBAHA.121.316925","volume":"41","author":"S Xiong","year":"2021","unstructured":"Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB. Interleukin-1RA mitigates SARS-CoV-2-Induced inflammatory lung vascular leakage and mortality in humanized K18-hACE-2 mice. Arterioscler Thromb Vasc Biol. 2021;41(11):2773\u201385. https:\/\/doi.org\/10.1161\/ATVBAHA.121.316925.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"835_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms18010022","volume":"18","author":"X Han","year":"2017","unstructured":"Han X, Zha H, Yang F, Guo B, Zhu B. Tumor-Derived tissue factor aberrantly activates complement and facilitates lung tumor progression via recruitment of Myeloid-Derived suppressor cells. Int J Mol Sci. 2017;18(1):22. https:\/\/doi.org\/10.3390\/ijms18010022. Published 2017 Jan 19.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"835_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cancers16020450","volume":"16","author":"A Charpidou","year":"2024","unstructured":"Charpidou A, Gerotziafas G, Popat S, et al. Lung cancer related thrombosis (LCART): focus on immune checkpoint Blockade. Cancers (Basel). 2024;16(2):450. https:\/\/doi.org\/10.3390\/cancers16020450. Published 20 Jan 2024.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"835_CR41","doi-asserted-by":"publisher","first-page":"e006072","DOI":"10.1136\/jitc-2022-006072","volume":"11","author":"AA Khorana","year":"2023","unstructured":"Khorana AA, Palaia J, Rosenblatt L, et al. Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer. J Immunother Cancer. 2023;11(1):e006072. https:\/\/doi.org\/10.1136\/jitc-2022-006072.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"835_CR42","doi-asserted-by":"publisher","first-page":"e010761","DOI":"10.1136\/jitc-2024-010761","volume":"13","author":"TA Sussman","year":"2025","unstructured":"Sussman TA, Giobbie-Hurder A, Dryg ID, et al. Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysis. J Immunother Cancer. 2025;13(5):e010761. https:\/\/doi.org\/10.1136\/jitc-2024-010761. Published 7 May 2024.","journal-title":"J Immunother Cancer"},{"key":"835_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.thromres.2020.03.003","volume":"189","author":"RA Hasan","year":"2020","unstructured":"Hasan RA, Koh AY, Zia A. The gut Microbiome and thromboembolism. Thromb Res. 2020;189:77\u201387. https:\/\/doi.org\/10.1016\/j.thromres.2020.03.003.","journal-title":"Thromb Res"},{"key":"835_CR44","doi-asserted-by":"publisher","first-page":"1301737","DOI":"10.3389\/fmicb.2024.1301737","volume":"15","author":"Q Xu","year":"2024","unstructured":"Xu Q, Fang J, Wang Y, Lang D, Xu B. The causal relationship between gut microbiota and lower extremity deep vein thrombosis combined with pulmonary embolism. Front Microbiol. 2024;15:1301737. https:\/\/doi.org\/10.3389\/fmicb.2024.1301737. Published 2 Oct 2024.","journal-title":"Front Microbiol"},{"issue":"5","key":"835_CR45","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/jth.15250","volume":"19","author":"IA Gimbel","year":"2021","unstructured":"Gimbel IA, Mulder FI, Bosch FTM, Freund JE, Guman N, van Es N, Kamphuisen PW, B\u00fcller HR, Middeldorp S. Pulmonary embolism at autopsy in cancer patients. J Thromb Haemost. 2021;19(5):1228\u201335. https:\/\/doi.org\/10.1111\/jth.15250. Epub 2021 Mar 26. PMID: 33501757; PMCID: PMC8252008.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"835_CR46","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/jth.15779","volume":"20","author":"BB Navi","year":"2022","unstructured":"Navi BB, Zhang C, Sherman CP, et al. Ischemic stroke with cancer: hematologic and embolic biomarkers and clinical outcomes. J Thromb Haemost. 2022;20(9):2046\u201357. https:\/\/doi.org\/10.1111\/jth.15779.","journal-title":"J Thromb Haemost"},{"key":"835_CR47","doi-asserted-by":"publisher","unstructured":"Lin SC, Liao YC, Chen PM et al. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling [published correction appears in J Biomed Sci. 2023;30(1):54. 10.1186\/s12929-023-00948-w.]. J Biomed Sci. 2022;29(1):109. https:\/\/doi.org\/10.1186\/s12929-022-00888-x.\u00a0Published 22 Dec 2022.","DOI":"10.1186\/s12929-022-00888-x"},{"issue":"1","key":"835_CR48","doi-asserted-by":"publisher","first-page":"2313362","DOI":"10.1080\/09537104.2024.2313362","volume":"35","author":"T Helin","year":"2024","unstructured":"Helin T, Palviainen M, Lemponen M, Maaninka K, Siljander P, Joutsi-Korhonen L. Increased Circulating platelet-derived extracellular vesicles in severe COVID-19 disease. Platelets. 2024;35(1):2313362. https:\/\/doi.org\/10.1080\/09537104.2024.2313362.","journal-title":"Platelets"},{"key":"835_CR49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fendo.2019.00471","volume":"10","author":"MG Kazanietz","year":"2019","unstructured":"Kazanietz MG, Durando M, Cooke M. CXCL13 and its receptor CXCR5 in cancer: Inflammation, immune Response, and beyond. Front Endocrinol (Lausanne). 2019;10:471. https:\/\/doi.org\/10.3389\/fendo.2019.00471. Published 12 Jul 2019.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"835_CR50","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41375-020-01063-7","volume":"35","author":"M Sivina","year":"2021","unstructured":"Sivina M, Xiao L, Kim E, et al. CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia. Leukemia. 2021;35(6):1610\u201320. https:\/\/doi.org\/10.1038\/s41375-020-01063-7.","journal-title":"Leukemia"},{"issue":"3","key":"835_CR51","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00277-023-05540-8","volume":"103","author":"HA Ahmed","year":"2024","unstructured":"Ahmed HA, Nafady A, Ahmed EH, et al. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia. Ann Hematol. 2024;103(3):781\u201392. https:\/\/doi.org\/10.1007\/s00277-023-05540-8.","journal-title":"Ann Hematol"},{"issue":"1","key":"835_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s43556-020-00002-3","volume":"1","author":"M Shen","year":"2020","unstructured":"Shen M, Di K, He H, et al. Progress in exosome associated tumor markers and their detection methods. Mol Biomed. 2020;1(1):3. https:\/\/doi.org\/10.1186\/s43556-020-00002-3. Published 14 Aug 2020.","journal-title":"Mol Biomed"},{"issue":"10","key":"835_CR53","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jtho.2016.05.034","volume":"11","author":"B Sandfeld-Paulsen","year":"2016","unstructured":"Sandfeld-Paulsen B, Jakobsen KR, B\u00e6k R, et al. Exosomal proteins as diagnostic biomarkers in lung cancer. J Thorac Oncol. 2016;11(10):1701\u201310. https:\/\/doi.org\/10.1016\/j.jtho.2016.05.034.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"835_CR54","first-page":"2226","volume":"12","author":"J Cheng","year":"2022","unstructured":"Cheng J, Wang X, Yuan X, Liu G, Chu Q. Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets. Am J Cancer Res. 2022;12(5):2226\u201348. Published 15 May 2022.","journal-title":"Am J Cancer Res"},{"key":"835_CR55","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1038\/srep06232","volume":"4","author":"K Ueda","year":"2014","unstructured":"Ueda K, Ishikawa N, Tatsuguchi A, Saichi N, Fujii R, Nakagawa H. Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of Circulating exosomes. Sci Rep. 2014;4:6232. https:\/\/doi.org\/10.1038\/srep06232. Published 29 Aug 2014.","journal-title":"Sci Rep"},{"issue":"5","key":"835_CR56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1590\/1806-9282.66.5.649","volume":"66","author":"S Kalkan","year":"2020","unstructured":"Kalkan S, Caliskan S. High D-dimer levels are associated with prostate cancer. Rev Assoc Med Bras (1992). 2020;66(5):649\u201353. https:\/\/doi.org\/10.1590\/1806-9282.66.5.649.","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"1","key":"835_CR57","doi-asserted-by":"publisher","first-page":"16432","DOI":"10.1038\/s41598-022-16582-9","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang X, Li W, Sun T, Dang C, Diao D. D-dimer, a predictor of bad outcome in gastric cancer patients undergoing radical resection. Sci Rep. 2022;12(1):16432. https:\/\/doi.org\/10.1038\/s41598-022-16582-9. Published 30 Sep 2022.","journal-title":"Sci Rep"},{"issue":"6","key":"835_CR58","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","volume":"104","author":"FI Mulder","year":"2019","unstructured":"Mulder FI, Candeloro M, Kamphuisen PW, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica. 2019;104(6):1277\u201387. https:\/\/doi.org\/10.3324\/haematol.2018.209114.","journal-title":"Haematologica"},{"issue":"10","key":"835_CR59","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/bloodadvances.2021006484","volume":"6","author":"TF Overvad","year":"2022","unstructured":"Overvad TF, Ording AG, Nielsen PB, et al. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy. Blood Adv. 2022;6(10):2967\u201376. https:\/\/doi.org\/10.1182\/bloodadvances.2021006484.","journal-title":"Blood Adv"},{"issue":"4","key":"835_CR60","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41416-023-02310-1","volume":"129","author":"N Joharatnam-Hogan","year":"2023","unstructured":"Joharatnam-Hogan N, Hatem D, Cafferty FH, et al. Thromboxane biosynthesis in cancer patients and its Inhibition by aspirin: a sub-study of the Add-Aspirin trial. Br J Cancer. 2023;129(4):706\u201320. https:\/\/doi.org\/10.1038\/s41416-023-02310-1.","journal-title":"Br J Cancer"},{"issue":"7","key":"835_CR61","doi-asserted-by":"publisher","first-page":"483","DOI":"10.6004\/jnccn.2024.0046","volume":"22","author":"MB Streiff","year":"2024","unstructured":"Streiff MB, Holmstrom B, Angelini D, et al. Cancer-Associated venous thromboembolic Disease, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(7):483\u2013506. https:\/\/doi.org\/10.6004\/jnccn.2024.0046.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"835_CR62","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1038\/s41598-023-30763-0","volume":"13","author":"Y Lan","year":"2023","unstructured":"Lan Y, Wu L, Guo J, et al. Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients. Sci Rep. 2023;13(1):3553. https:\/\/doi.org\/10.1038\/s41598-023-30763-0. Published 2 Mar 2023.","journal-title":"Sci Rep"},{"issue":"3","key":"835_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.6004\/jadpro.2023.14.3.6","volume":"14","author":"K Halsema","year":"2023","unstructured":"Halsema K, Mcmahon B, Cancer-Associated, Thrombosis. Risk Assessment, Prevention, and treatment. J Adv Pract Oncol. 2023;14(3):213\u20137. https:\/\/doi.org\/10.6004\/jadpro.2023.14.3.6.","journal-title":"J Adv Pract Oncol"},{"key":"835_CR64","doi-asserted-by":"publisher","first-page":"107602962097104","DOI":"10.1177\/1076029620971041","volume":"26","author":"K Zhou","year":"2020","unstructured":"Zhou K, Zhang J, Zheng ZR, et al. Diagnostic and prognostic value of TAT, PIC, TM, and t-PAIC in malignant tumor patients with venous thrombosis. Clin Appl Thromb Hemost. 2020;26:1076029620971041. https:\/\/doi.org\/10.1177\/1076029620971041.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"835_CR65","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/biomedicines11051384","volume":"11","author":"CY Huang","year":"2023","unstructured":"Huang CY, Wei PL, Prince GMSH, et al. The role of thrombomodulin in estrogen-receptor-positive breast cancer progression, metastasis, and curcumin sensitivity. Biomedicines. 2023;11(5):1384. https:\/\/doi.org\/10.3390\/biomedicines11051384. Published 7 May 2023.","journal-title":"Biomedicines"},{"key":"835_CR66","doi-asserted-by":"publisher","first-page":"104867","DOI":"10.1016\/j.ijnurstu.2024.104867","volume":"159","author":"X Huang","year":"2024","unstructured":"Huang X, Chen H, Meng S, et al. External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis. Int J Nurs Stud. 2024;159:104867. https:\/\/doi.org\/10.1016\/j.ijnurstu.2024.104867.","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"835_CR67","doi-asserted-by":"publisher","first-page":"220","DOI":"10.21037\/jgo-23-18","volume":"14","author":"L Qin","year":"2023","unstructured":"Qin L, Liang Z, Xie J, et al. Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study. J Gastrointest Oncol. 2023;14(1):220\u201332. https:\/\/doi.org\/10.21037\/jgo-23-18.","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"835_CR68","doi-asserted-by":"publisher","first-page":"e000948","DOI":"10.1136\/esmoopen-2020-000948","volume":"5","author":"AA Khorana","year":"2020","unstructured":"Khorana AA, Cohen AT, Carrier M, et al. Prevention of venous thromboembolism in ambulatory patients with cancer. ESMO Open. 2020;5(6):e000948. https:\/\/doi.org\/10.1136\/esmoopen-2020-000948.","journal-title":"ESMO Open"},{"issue":"1","key":"835_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10147-022-02257-y","volume":"28","author":"Y Tsubata","year":"2023","unstructured":"Tsubata Y, Kawakado K, Hamai K, et al. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE\/NEJ037 study data. Int J Clin Oncol. 2023;28(1):69\u201378. https:\/\/doi.org\/10.1007\/s10147-022-02257-y.","journal-title":"Int J Clin Oncol"},{"issue":"Suppl 1","key":"835_CR70","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/ajh.27273","volume":"99","author":"Y Tera","year":"2024","unstructured":"Tera Y, Suh YJ, Fainchtein K, Agrawal A, Mates M, Othman M. Assessing hypercoagulability and VTE risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy. Am J Hematol. 2024;99(Suppl 1):S19\u201327. https:\/\/doi.org\/10.1002\/ajh.27273.","journal-title":"Am J Hematol"},{"issue":"3","key":"835_CR71","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ijcard.2014.03.109","volume":"173","author":"M Arcopinto","year":"2014","unstructured":"Arcopinto M, Cella CA, Wesolowski R, et al. Primary prevention of cancer-related thrombosis: special focus on ambulatory patients. Int J Cardiol. 2014;173(3):583\u20134. https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.109.","journal-title":"Int J Cardiol"},{"issue":"2","key":"835_CR72","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5853\/jos.2023.03279","volume":"26","author":"JH Heo","year":"2024","unstructured":"Heo JH, Yun J, Kim KH, et al. Cancer-Associated stroke: thrombosis Mechanism, Diagnosis, Outcome, and therapeutic strategies. J Stroke. 2024;26(2):164\u201378. https:\/\/doi.org\/10.5853\/jos.2023.03279.","journal-title":"J Stroke"},{"issue":"2","key":"835_CR73","doi-asserted-by":"publisher","first-page":"117","DOI":"10.17925\/HI.2022.16.2.117","volume":"16","author":"RK Ramcharitar","year":"2022","unstructured":"Ramcharitar RK, Man L, Khaja MS, Barnett ME, Sharma A. A review of the Past, present and future of Cancer-associated thrombosis management. Heart Int. 2022;16(2):117\u201323. https:\/\/doi.org\/10.17925\/HI.2022.16.2.117. Published 23 Aug 2022.","journal-title":"Heart Int"},{"key":"835_CR74","doi-asserted-by":"publisher","unstructured":"Zaki HA, Hamdi Alkahlout B, Basharat K et al. Low-Molecular-Weight Heparin Versus Warfarin in Adult Cancer Patients as a Precision Medicine for Thrombosis: A Systematic Review and Meta-Analysis. Cureus. 2023;15(7):e41268. https:\/\/doi.org\/10.7759\/cureus.41268. Published 1 Jul 2023","DOI":"10.7759\/cureus.41268"},{"issue":"3\u20134","key":"835_CR75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jdmv.2023.09.001","volume":"48","author":"A Yannoutsos","year":"2023","unstructured":"Yannoutsos A, Cacciatore C, Jaouen S, Farge D, Frere C. Treatment of cancer-associated venous thromboembolism: A focus on special populations. J Med Vasc. 2023;48(3\u20134):124\u201335. https:\/\/doi.org\/10.1016\/j.jdmv.2023.09.001.","journal-title":"J Med Vasc"},{"issue":"10","key":"835_CR76","doi-asserted-by":"publisher","first-page":"e069742","DOI":"10.1136\/bmjopen-2022-069742","volume":"13","author":"C Wang","year":"2023","unstructured":"Wang C, Ning YC, Song LP, et al. Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trial. BMJ Open. 2023;13(10):e069742. https:\/\/doi.org\/10.1136\/bmjopen-2022-069742. Published 25 Oct 2023.","journal-title":"BMJ Open"},{"issue":"12","key":"835_CR77","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1111\/jth.15516","volume":"19","author":"FTM Bosch","year":"2021","unstructured":"Bosch FTM, Mulder FI, Huisman MV, et al. Risk factors for Gastrointestinal bleeding in patients with Gastrointestinal cancer using Edoxaban. J Thromb Haemost. 2021;19(12):3008\u201317. https:\/\/doi.org\/10.1111\/jth.15516.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"835_CR78","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1186\/s12885-022-10403-y","volume":"22","author":"M Nakamura","year":"2022","unstructured":"Nakamura M, Ishiguro A, Dazai M, et al. Feasibility of Edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with Gastrointestinal cancer: excave study. BMC Cancer. 2022;22(1):1322. https:\/\/doi.org\/10.1186\/s12885-022-10403-y. Published 2022 Dec 16.","journal-title":"BMC Cancer"},{"issue":"10","key":"835_CR79","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/biomedicines12102230","volume":"12","author":"AM Fioretti","year":"2024","unstructured":"Fioretti AM, La Forgia D, Scicchitano P, et al. Inferior Vena Cava filter in Cancer-Associated thrombosis: A vade mecum for the treating physicians: A narrative review. Biomedicines. 2024;12(10):2230. https:\/\/doi.org\/10.3390\/biomedicines12102230. Published 2024 Sep 30.","journal-title":"Biomedicines"},{"issue":"2","key":"835_CR80","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1055\/s-0036-1581090","volume":"33","author":"MB Pandhi","year":"2016","unstructured":"Pandhi MB, Desai KR, Ryu RK, Lewandowski RJ. The role of inferior Vena Cava filters in cancer patients. Semin Intervent Radiol. 2016;33(2):71\u20134. https:\/\/doi.org\/10.1055\/s-0036-1581090.","journal-title":"Semin Intervent Radiol"},{"issue":"9","key":"835_CR81","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jtha.2023.04.044","volume":"21","author":"A Jarrahi","year":"2023","unstructured":"Jarrahi A, Khodadadi H, Moore NS, et al. Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation. J Thromb Haemost. 2023;21(9):2473\u201384. https:\/\/doi.org\/10.1016\/j.jtha.2023.04.044.","journal-title":"J Thromb Haemost"},{"key":"835_CR82","doi-asserted-by":"publisher","unstructured":"Li J, Xia Y, Sun B et al. Neutrophil extracellular traps induced by the hypoxic microenvironment in gastric cancer augment tumour growth. Cell Commun Signal. 2023;21(1):86. Published 2023 May 1. https:\/\/doi.org\/10.1186\/s12964-023-01112-5","DOI":"10.1186\/s12964-023-01112-5"},{"issue":"21","key":"835_CR83","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/cells13211778","volume":"13","author":"TS Lien","year":"2024","unstructured":"Lien TS, Sun DS, Chang HH. Targeted delivery to dying cells through P-Selectin-PSGL-1 axis: A promising strategy for enhanced drug efficacy in liver injury models. Cells. 2024;13(21):1778. https:\/\/doi.org\/10.3390\/cells13211778. Published 27 Oct 2024.","journal-title":"Cells"},{"key":"835_CR84","doi-asserted-by":"publisher","unstructured":"Kumar A, Taghi Khani A, Sanchez Ortiz A, Swaminathan S. GM-CSF: A Double-Edged Sword in Cancer Immunotherapy. Front Immunol. 2022;13:901277. Published 2022 Jul 5. https:\/\/doi.org\/10.3389\/fimmu.2022.901277","DOI":"10.3389\/fimmu.2022.901277"},{"issue":"5","key":"835_CR85","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/j.clml.2024.12.013","volume":"25","author":"HK Al-Ali","year":"2025","unstructured":"Al-Ali HK, Gerds AT, Grunwald MR, Yu J. A review of Real-World experience with ruxolitinib for myelofibrosis. Clin Lymphoma Myeloma Leuk. 2025;25(5):e262\u201381. https:\/\/doi.org\/10.1016\/j.clml.2024.12.013.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"835_CR86","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3390\/nu11061363","volume":"11","author":"SM Bozonet","year":"2019","unstructured":"Bozonet SM, Carr AC. The role of physiological vitamin C concentrations on key functions of neutrophils isolated from healthy individuals. Nutrients. 2019;11(6):1363. https:\/\/doi.org\/10.3390\/nu11061363. Published 2019 Jun 17.","journal-title":"Nutrients"},{"key":"835_CR87","doi-asserted-by":"publisher","first-page":"6872621","DOI":"10.1155\/2018\/6872621","volume":"2018","author":"H Gao","year":"2018","unstructured":"Gao H, Dai W, Zhao L, Min J, Wang F. The role of zinc and zinc homeostasis in macrophage function. J Immunol Res. 2018;2018:6872621. https:\/\/doi.org\/10.1155\/2018\/6872621. Published 2018 Dec 6.","journal-title":"J Immunol Res"},{"issue":"6","key":"835_CR88","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1532-5415.2011.03406.x","volume":"59","author":"P Vergidis","year":"2011","unstructured":"Vergidis P, Hamer DH, Meydani SN, Dallal GE, Barlam TF. Patterns of antimicrobial use for respiratory tract infections in older residents of long-term care facilities. J Am Geriatr Soc. 2011;59(6):1093\u20138. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03406.x.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"835_CR89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/a-2374-3425","volume":"45","author":"C Hart","year":"2025","unstructured":"Hart C, van Es N, Voigtlaender M. Primary prevention of Cancer-Associated thrombosis: current perspectives. Hamostaseologie. 2025;45(2):127\u201338. https:\/\/doi.org\/10.1055\/a-2374-3425.","journal-title":"Hamostaseologie"},{"key":"835_CR90","doi-asserted-by":"publisher","unstructured":"Twine CP, Kakkos SK, Aboyans V, et al. editors. \u2018s Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. Eur J Vasc Endovasc Surg. 2023;65(5):627\u2013689. https:\/\/doi.org\/10.1016\/j.ejvs.2023.03.042","DOI":"10.1016\/j.ejvs.2023.03.042"},{"issue":"6478","key":"835_CR91","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"issue":"11","key":"835_CR92","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.jtha.2023.07.005","volume":"21","author":"T Shirai","year":"2023","unstructured":"Shirai T, Tsukiji N, Sasaki T, et al. Cancer-associated fibroblasts promote venous thrombosis through podoplanin\/CLEC-2 interaction in podoplanin-negative lung cancer mouse model. J Thromb Haemost. 2023;21(11):3153\u201365. https:\/\/doi.org\/10.1016\/j.jtha.2023.07.005.","journal-title":"J Thromb Haemost"},{"issue":"12","key":"835_CR93","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41416-022-01968-3","volume":"127","author":"S Koizume","year":"2022","unstructured":"Koizume S, Miyagi Y. Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications. Br J Cancer. 2022;127(12):2099\u2013107. https:\/\/doi.org\/10.1038\/s41416-022-01968-3.","journal-title":"Br J Cancer"},{"issue":"2","key":"835_CR94","doi-asserted-by":"publisher","first-page":"102359","DOI":"10.1016\/j.rpth.2024.102359","volume":"8","author":"H Doubre","year":"2024","unstructured":"Doubre H, Monnet I, Azarian R, et al. Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival. Res Pract Thromb Haemost. 2024;8(2):102359. https:\/\/doi.org\/10.1016\/j.rpth.2024.102359. Published 2024 Mar 1.","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"835_CR95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11239-023-02916-5","volume":"57","author":"Y Su","year":"2024","unstructured":"Su Y, Yi J, Zhang Y, et al. EML4-ALK fusion protein in lung cancer cells enhances venous thrombogenicity through the pERK1\/2-AP-1-tissue factor axis. J Thromb Thrombolysis. 2024;57(1):67\u201381. https:\/\/doi.org\/10.1007\/s11239-023-02916-5.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"835_CR96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13568-025-01903-8","volume":"15","author":"PF Cheng","year":"2025","unstructured":"Cheng PF, Wang JX, Wu JS, Li GM. Gut microbiota, plasma metabolites, and venous thromboembolism: a Mendelian randomization study. AMB Express. 2025;15(1):97. https:\/\/doi.org\/10.1186\/s13568-025-01903-8. Published 2025 Jun 20.","journal-title":"AMB Express"},{"issue":"5","key":"835_CR97","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1164\/rccm.201907-1487OC","volume":"201","author":"RP Dickson","year":"2020","unstructured":"Dickson RP, van der Schultz MJ, et al. Lung microbiota predict clinical outcomes in critically ill patients. Am J Respir Crit Care Med. 2020;201(5):555\u201363. https:\/\/doi.org\/10.1164\/rccm.201907-1487OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"835_CR98","doi-asserted-by":"publisher","unstructured":"Zhang Z, Chen H, Huang J et al. Early Administration of Vancomycin Inhibits Pulmonary Embolism by Remodeling Gut Microbiota. J Pers Med. 2023;13(3):537. https:\/\/doi.org\/10.3390\/jpm13030537 Published 17 Mar 2023.","DOI":"10.3390\/jpm13030537"},{"issue":"11","key":"835_CR99","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3390\/cancers16112082","volume":"16","author":"AG Tsantes","year":"2024","unstructured":"Tsantes AG, Petrou E, Tsante KA, et al. Cancer-Associated thrombosis: Pathophysiology, laboratory Assessment, and current guidelines. Cancers (Basel). 2024;16(11):2082. https:\/\/doi.org\/10.3390\/cancers16112082. Published 30 May 2024.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"835_CR100","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/CAD.0000000000001713","volume":"36","author":"M Weng","year":"2025","unstructured":"Weng M, Zhu X. Thrombospondin-2 induces M2 macrophage polarization through fatty acid metabolism to drive lung adenocarcinoma proliferation. Anticancer Drugs. 2025;36(6):459\u201367. https:\/\/doi.org\/10.1097\/CAD.0000000000001713.","journal-title":"Anticancer Drugs"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00835-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:02:22Z","timestamp":1772049742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00835-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["835"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00835-y","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original publication was amended to correct the funding information.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}